Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease? Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Pulmonary hypertension in chronic interstitial lung diseases}, Source: Eur Respir Rev 2013; 22: 292-301 Year: 2013
The association of lung cancer with pulmonary fibrosis Source: ERJ Open Res, 8 (1) 00505-2021; 10.1183/23120541.00505-2021 Year: 2022
Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation Source: Eur Respir J 2012; 39: 1520-1533 Year: 2012
Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020
Histology of lung cancer and pulmonary embolism. Are they related? Source: Virtual Congress 2021 – Pulmonary embolism in non-COVID-19 and COVID-19 patients Year: 2021
Two-stage treatment of non-small cell lung cancer (NSCLC) in patients with severe coronary heart disease. Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Severe pulmonary hypertension in lung disease: phenotypes and response to treatment Source: Eur Respir J 2015; 46: 1378-1389 Year: 2015
The impact of chronic obstructive pulmonary disease on survival of the patients with small-cell lung cancer Source: International Congress 2015 – Diagnosis and therapy of lung cancer Year: 2015
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021
Chronic obstructive pulmonary disease and interstitial lung disease could predict poor long-term survivals after pulmonary resection for lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 38s Year: 2002
Clinicopathologic features of patients with non-small cell lung cancer and chronic obstructive pulmonary disease undergoing lung cancer surgery Source: Virtual Congress 2020 – Localised non-small cell lung cancer Year: 2020
Diagnosing COPD and targeted lung cancer screening}, Source: Eur Respir J 2012; 40: 1063-1064 Year: 2012
A case of lung cancer complicated with pulmonary thromboemboli Source: Eur Respir J 2006; 28: Suppl. 50, 93s Year: 2006
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Comparison of pulmonary hypertension (PH) associated to chronic lung disease to other PH groups Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016
Systemic manifestations and comorbidities of COPD Source: Eur Respir J 2009; 33: 1165-1185 Year: 2009
Chronic obstructive pulmonary disease is an independent risk factor for nonsmall cell lung cancer in smokers Source: Eur Respir J 2002; 20: Suppl. 38, 254s Year: 2002
Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
Noninfectious pulmonary complications after organ transplantation Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=202 Year: 2005